Dr. Ranjana K. Kanchan is a cancer biologist whose research centers on mitotic regulation, chromosomal instability, and ferroptosis in aggressive cancers, with a primary focus on pediatric brain tumors such as medulloblastoma. Her work investigates kinetochore signaling (including NDC80-dependent pathways), MYC-driven oncogenesis, and cell death vulnerabilities to develop targeted therapeutic strategies. She combines molecular oncology, live-cell imaging, and preclinical models to advance translational cancer therapies.